文献速递类风湿关节炎

类风湿关节炎中B细胞辅助T细胞的定义及其治疗中的变化

Definition of B cell helper T cells in rheumatoid arthritis and their behavior during treatment.
PubMed 文献 · Semin Arthritis Rheum · 2020-07-13

本文综述了类风湿关节炎(RA)中滤泡辅助性T细胞(Tfh)和外周辅助性T细胞(Tph)在发病机制及治疗应答中的作用。多数报道显示RA患者循环Tph和Tfh细胞频率较健康对照增加,且治疗可调节其频率;阿巴西普启动前ICOS表达血Tfh细胞比例可独立预测第24周DAS28-ESR改善。

要点

  • RA患者滑膜和血液中可检测到Tfh和Tph细胞,循环频率多较健康对照增加。
  • 循环Tfh和Tph细胞频率随RA治疗性质和持续时间而调节。
  • 阿巴西普前ICOS+血Tfh比例可预测第24周DAS28-ESR改善。

核心结论

  • 循环Tfh和Tph细胞可能参与RA发病机制及治疗应答。

研究设计与样本

  • 本文为文献综述,聚焦RA中专门辅助B细胞的Tfh和Tph细胞及其在治疗中的调节。

主要发现

  • Tfh细胞及更高比例的Tph细胞见于RA患者滑膜组织和滑液中。
  • 多数报道显示RA患者循环Tph和Tfh细胞频率较健康对照增加。
  • 疾病活动度评分与效应或活化循环Tfh细胞亚群的相关性存在不一致。
  • 循环Tfh和Tph细胞频率取决于RA治疗的性质和持续时间。
  • 阿巴西普启动前ICOS表达血Tfh细胞比例是第24周DAS28-ESR改善的独立显著预测因子。

关键数值与推荐

  • 阿巴西普启动前ICOS表达血Tfh细胞比例可独立显著预测第24周DAS28-ESR改善。

临床怎么用

  • 可关注循环Tfh和Tph细胞作为RA治疗应答预测生物标志物的潜力。

局限性

  • 疾病活动度与Tfh亚群相关性不一致,可能源于队列设计、疾病活动定义、队列大小及治疗差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunopathogenesis of rheumatoid arthritis (RA) is not yet clearly defined. Besides known B-cell involvement, RA development and evolution involves CD4+ T helper cell homeostasis dysregulation. Imbalance between Th17 cells and regulatory T cells have been reported and may contribute to sustained inflammation. Since the last decade, increasing reports focused on a newly described CD4+ T helper cell subset, called T follicular helper (Tfh) cells, functionally distinct from other subsets due to their own property to provide help to B cells by enhancing their survival and differentiation into long-lasting antibody secreting cells. More recently, another B cell helper subset, named T peripheral helper (Tph) cells, has been specifically described in synovial tissues and blood of RA patients. METHODS: We conducted an exhaustive and careful literature search focusing our interest on T cells specialized on B cell help, Tfh cells and Tph cells, in RA pathogenesis and focused on their modulation during treatments. RESULTS: Tfh cells and in higher proportions Tph cells were described in synovial tissue and liquid of RA patients. In blood of RA patients, despite the use of diverse Tfh cell definitions, a vast majority of reports revealed an increase of circulating Tph and Tfh cell frequency, compared to healthy controls. However, discordant correlations between disease activity score and either effector or activated circulating Tfh cell subsets were highlighted, probably due to heterogeneity of cohort design in term of definition of disease activity, cohort size and use of different treatments. Indeed, frequencies of circulating Tfh and Tph cells are modulated depending on the nature and duration of RA treatment. Interestingly, it has been demonstrated that the proportion of ICOS-expressing blood Tfh cells before abatacept initiation was an independent and significant predictor of DAS28-ESR improvement at week 24. This report may encourage to conduct further investigations based on T-cell subsets as predictive biomarkers of response to biotherapies. CONCLUSION: Mounting evidences hypothesize that circulating Tfh and Tph cells may be involved in RA pathogenesis and response to treatment.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Lucas C, Perdriger A, Amé P, et al. Definition of B cell helper T cells in rheumatoid arthritis and their behavior during treatment. Semin Arthritis Rheum. 2020. PMID: 32896702. doi:10.1016/j.semarthrit.2020.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。